No cases of myocarditis or pericarditis following the use of the mRNA Covid-19 vaccine have been detected in Malaysia thus far, said Health director-general Dr Noor Hisham Abdullah.

He said the National Pharmaceutical Regulatory Agency (NPRA) had conducted risk assessments on safety issues related to the matter, based on information obtained from regulatory bodies and international references...